| 1 |
33761503 | Successful Multimodality Management of Atypical Teratoid/Rhabdoid Tumour of the Lower Dorsal Spine with Spinal Drop Metastasis: Illustrated Review. | 2021 |
1 |
| 2 |
31122751 | [Primary central nervous system lymphoma following immunotherapy for metastatic melanoma]. | 2019 Oct |
1 |
| 3 |
29366426 | ICE Regimen for Relapsed/Refractory Bone and Soft Tissue Sarcomas in Children. | 2018 |
1 |
| 4 |
26221234 | Promising response of anaplastic lymphoma kinase-positive large B-cell lymphoma to crizotinib salvage treatment: case report and review of literature. | 2015 |
1 |
| 5 |
24944079 | Factors determining pbsc mobilization efficiency and nonmobilization following ICE with or without rituximab (R-ICE) salvage therapy for refractory or relapsed lymphoma prior to autologous transplantation. | 2014 Dec |
2 |
| 6 |
22525550 | Emergency hemicolectomy for intestinal primary aspergillosis in acute myeloid leukemia. | 2012 Mar |
1 |
| 7 |
22099936 | Did salvage ICE chemotherapy improve the outcome in primary resistant/relapsing stage III/IV neuroblastoma? | 2011 Mar |
1 |
| 8 |
19701081 | High dose chemoradiotherapy and ASCT may overcome the prognostic importance of biologic markers in relapsed/refractory Hodgkin lymphoma. | 2010 Jan |
1 |
| 9 |
16234294 | Bevacizumab plus high-dose ifosfamide, etoposide and carboplatin (HD-ICE) as third-line salvage chemotherapy induced an unexpected dramatic response in highly platinum refractory germ-cell cancer. | 2006 Mar |
1 |
| 10 |
16702184 | Pretreatment prognostic factors and outcome in patients with relapsed or primary-refractory diffuse large B-cell lymphoma treated with second-line chemotherapy and autologous stem cell transplantation. | 2006 May |
1 |
| 11 |
16772877 | Treatment of stage IV malignant rhabdoid tumor of the kidney (MRTK) with ICE and VDCy: a case report. | 2006 May |
1 |
| 12 |
15287915 | ICE (ifosfamide, carboplatin, etoposide) as second-line chemotherapy in relapsed or primary progressive aggressive lymphoma--the Nordic Lymphoma Group experience. | 2004 Sep |
2 |
| 13 |
11995407 | Delayed administration of G-CSF until day +7 after autologous peripheral blood stem cell transplant is as effective in accelerating hematopoietic as day 0. | 2002 Jan-Feb |
1 |
| 14 |
12215019 | Risk of neutropenic fever and early infectious complications after autologous peripheral blood stem cell transplantation for malignant diseases. | 2002 Aug |
1 |
| 15 |
8677446 | Dose-intensive ifosfamide for the treatment of non-Hodgkin's lymphoma. | 1996 Jun |
1 |
| 16 |
8677454 | Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study. | 1996 Jun |
1 |
| 17 |
8899175 | The ICE regimen (ifosfamide, carboplatin, etoposide) for the treatment of germ-cell tumors and metastatic trophoblastic disease. | 1996 Sep |
1 |
| 18 |
7610398 | Ifosfamide/carboplatin/etoposide chemotherapy for metastatic breast cancer with or without autologous hematopoietic stem cell transplantation: evaluation of dose-response relationships. | 1995 Jun |
1 |
| 19 |
7871269 | [Therapeutic intensification and hematopoietic stem cell autotransplantation in the treatment of solid tumors in adults: principles, realization and application to the treatment of germ cell, trophoblastic, breast, ovarian and small-cell bronchial tumors. 1]. | 1995 |
1 |
| 20 |
8133538 | Phase I study of escalating targeted doses of carboplatin combined with ifosfamide and etoposide in treatment of newly diagnosed pediatric solid tumors. | 1994 Apr 6 |
1 |
| 21 |
8445431 | Phase I study of escalating targeted doses of carboplatin combined with ifosfamide and etoposide in children with relapsed solid tumors. | 1993 Mar |
1 |